<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Techniques for radiofrequency ablation for the treatment of lower extremity chronic venous disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Techniques for radiofrequency ablation for the treatment of lower extremity chronic venous disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Techniques for radiofrequency ablation for the treatment of lower extremity chronic venous disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sherry Scovell, MD, FACS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 28, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Radiofrequency ablation (RFA) is a minimally invasive percutaneous technique using thermal energy to ablate incompetent veins. The device is used primarily to treat insufficiency of the axial veins (ie, great, small, accessory saphenous veins), but perforator veins can also be treated with a specialized radiofrequency stylet. </p><p>Alternative approaches to the treatment of superficial venous reflux using other thermal (eg, laser) and nonthermal (open surgery or liquid, foam, or glue sclerotherapy) ablation techniques, and open surgical ligation and stripping, are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15198.html" rel="external">"Techniques for endovenous laser ablation for the treatment of lower extremity chronic venous disease"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/8206.html" rel="external">"Injection sclerotherapy techniques for the treatment of telangiectasias, reticular veins, and small varicose veins"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/8176.html" rel="external">"Laser and light therapy of lower extremity telangiectasias, reticular veins, and small varicose veins"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Intervention for axial vein reflux'</a>.)</p><p></p><p class="headingAnchor" id="H2898004240"><span class="h1">ANATOMY</span></p><p class="headingAnchor" id="H34244921"><span class="h2">Venous anatomy</span><span class="headingEndMark"> — </span>The veins of the lower extremity are divided into superficial, perforator, and deep veins  (<a class="graphic graphic_figure graphicRef55019 graphicRef52340" href="/d/graphic/55019.html" rel="external">figure 1A-B</a>). The superficial veins lie superficial to the muscle fascia. The perforator veins cross the fascia and connect the superficial veins to the deep veins that are located beneath the fascia.</p><p>The main superficial veins of the lower extremity include the great and small saphenous veins. These and the accessory saphenous veins are collectively referred to as the axial veins. (See  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'Superficial venous system (As)'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>The great saphenous vein is the longest vein in the body and originates on the medial aspect of the dorsal foot. It crosses anterior to the medial malleolus and ascends along the medial aspect of the leg and thigh. Just below the inguinal ligament, it enters the fossa ovalis and terminates in the common femoral vein at the saphenofemoral junction. Anatomic variations in the great saphenous vein have implications for great saphenous venous ablation  (<a class="graphic graphic_figure graphicRef113245" href="/d/graphic/113245.html" rel="external">figure 2</a>). (See <a class="local">'Great saphenous vein'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The small saphenous vein originates laterally from the dorsal venous arch of the foot, crosses posterior to the lateral malleolus, and ascends in the posterior calf  (<a class="graphic graphic_figure graphicRef55019 graphicRef52340" href="/d/graphic/55019.html" rel="external">figure 1A-B</a>). In the upper calf, the small saphenous vein passes through the deep muscle fascia and terminates in the popliteal vein; however, the anatomy at the saphenopopliteal junction is variable  (<a class="graphic graphic_figure graphicRef82053" href="/d/graphic/82053.html" rel="external">figure 3</a>) [<a href="#rid1">1-4</a>]. The small saphenous vein can join a superficial cephalad extension in the posterior thigh (vein of Giacomini), connect to both the popliteal vein and the posterior thigh vein, or join the popliteal vein with no major tributaries near the junction  (<a class="graphic graphic_figure graphicRef82053" href="/d/graphic/82053.html" rel="external">figure 3</a>). Anatomic variations in the small saphenous vein have implications for small saphenous venous ablation [<a href="#rid4">4</a>]. (See <a class="local">'Small saphenous vein'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The accessory saphenous veins are any of several venous segments that ascend parallel to the great saphenous vein. Anterior accessory saphenous veins are located anteriorly and can be found in the thigh or leg  (<a class="graphic graphic_figure graphicRef55019 graphicRef52340" href="/d/graphic/55019.html" rel="external">figure 1A-B</a>) [<a href="#rid5">5</a>]. </p><p></p><p>The deep veins of the lower extremity are contained within the deep muscle compartments bounded by the muscle fascia  (<a class="graphic graphic_figure graphicRef75219" href="/d/graphic/75219.html" rel="external">figure 4</a>). (See  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'Deep venous system (Ad)'</a>.)</p><p>Perforator veins are those veins that traverse the muscular fascia to connect superficial veins with the deep veins. They are located anteriorly, posteriorly, laterally, and medially in both the thigh and calf. The normal flow in the perforator veins is from superficial to deep; however, many perforator veins demonstrate bidirectional flow. When the perforator veins are incompetent, flow is from deep to superficial. The most clinically significant perforator veins connect the posterior arch vein to the posterior tibial vein. These veins, termed posterior tibial perforators, were formerly known as Cockett's perforators. (See  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders"</a> and  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'Perforator veins (Ap)'</a>.)</p><p class="headingAnchor" id="H2997667410"><span class="h2">Saphenous nerve</span><span class="headingEndMark"> — </span>The saphenous nerve  (<a class="graphic graphic_figure graphicRef66562 graphicRef52007" href="/d/graphic/66562.html" rel="external">figure 5A-B</a>) is a terminal branch, and the largest cutaneous branch, of the femoral nerve and provides sensory innervation to the medial aspect of the lower leg. It passes through the adductor canal, after which it becomes superficial and closely related to the saphenous vein. The saphenous nerve is most vulnerable to injury in the distal calf, where it is adherent to the saphenous vein [<a href="#rid6">6</a>]. (See <a class="local">'Nerve injury'</a> below.)</p><p class="headingAnchor" id="H3420196371"><span class="h2">Sural nerve</span><span class="headingEndMark"> — </span>The sural nerve is a cutaneous nerve coursing along the small saphenous vein and traversing posterior to the lateral malleolus toward the fifth toe  (<a class="graphic graphic_figure graphicRef62917" href="/d/graphic/62917.html" rel="external">figure 6</a>). Identiﬁcation of the relative anatomy of the sural nerve to the small saphenous vein is important to avoid thermal injury to the sural nerve during radiofrequency ablation. (See <a class="local">'Nerve injury'</a> below.)</p><p>In an autopsy study, the sural nerve was noted to be separated from the small saphenous vein by the deep muscular fascia above the inferior border of the gastrocnemius muscle; however, below the inferior border of the gastrocnemius muscle, the sural nerve perforates the deep fascia and runs in close proximity to the small saphenous vein, where it can easily be injured [<a href="#rid7">7</a>]. The sural nerve can vary in its course from the usual anatomy in up to one half of patients and can usually be identified using ultrasound [<a href="#rid8">8</a>]. </p><p class="headingAnchor" id="H2419133107"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>The indications for radiofrequency ablation (RFA) are the same as for other venous ablation techniques [<a href="#rid9">9</a>]. In brief, patients with persistent symptoms and signs of superficial venous disease and documented axial venous reflux (ie, retrograde flow &gt;500 ms for superficial or perforator veins) are candidates for treatment. The patient's symptoms should directly correlate to the incompetent veins being treated. For patients with ulceration who are refractory to medical management or have recurrent ulceration, RFA of perforator veins may help heal ulcers and prevent recurrence. (See <a class="local">'Specific anatomic sites'</a> below and  <a class="medical medical_review" href="/d/html/8181.html" rel="external">"Overview of lower extremity chronic venous disease", section on 'Symptomatic'</a> and  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Candidates for venous intervention'</a>.) </p><p class="headingAnchor" id="H3"><span class="h2">Relative contraindications</span><span class="headingEndMark"> — </span>RFA generally should not be performed in patients who have signs of acute venous thrombosis (superficial, deep). However, case reports have documented potential benefit from early endovenous ablation in patients with superficial vein thrombosis of the distal great saphenous vein with a thrombus-free segment proximally [<a href="#rid10">10,11</a>]. In such circumstances, the catheter is never passed through the clot burden. </p><p>Pregnant patients should defer treatment until after delivery.</p><p>Patients with mixed arterial/venous ulcers are difficult to manage, and the patient should be referred to a vascular specialist. When severe arterial disease and coexisting venous disease is identified, the arterial disease may need to be addressed first. (See  <a class="medical medical_review" href="/d/html/8208.html" rel="external">"Clinical features and diagnosis of lower extremity peripheral artery disease"</a>.) </p><p>To successfully perform RFA, the vein to be treated should generally have a diameter exceeding 5 mm to facilitate vessel access with ultrasound and to easily accommodate the device. Large veins are a relative contraindication to RFA. While vein diameter greater than 8 to 10 mm may have a higher risk of nonclosure or thrombotic complications [<a href="#rid12">12-14</a>], alterations in technique can be usually used to manage larger veins safely. (See <a class="local">'Large veins'</a> below and <a class="local">'Endovenous heat-induced thrombus'</a> below.) </p><p>Very large diameter (&gt;20 mm) of the proximal saphenous vein represents a venous aneurysm and is best managed with high ligation and resection of the aneurysm. The remainder of the incompetent great saphenous vein in the thigh can then be ablated using standard techniques. </p><p class="headingAnchor" id="H1725479791"><span class="h1">PATIENT COUNSELING</span><span class="headingEndMark"> — </span>The decision to offer radiofrequency ablation (RFA) depends upon symptoms, response to initial medical therapy, extent of lower extremity venous disease, and patient expectations. The patient should be made aware that:</p><p class="bulletIndent1"><span class="glyph">●</span>Unforeseen anatomic issues may result in technical failure (ie, the inability to perform an endovenous procedure), in which case the patient may need to be rescheduled for a repeat or alternative procedure. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In spite of successful technical application of the RFA device, nonclosure of the vein (primary failure) or late secondary failure (ie, vein recanalization) may occur and may be more common in larger-diameter veins. In these cases, RFA may be repeated, or an alternative procedure can be performed. (See <a class="local">'Saphenous ablation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Whether to perform simultaneous phlebectomy or sclerotherapy at the same time as RFA versus delayed treatment of any residual veins should be discussed, as well as the benefits and risks of each approach. The advantages and disadvantages of each approach are discussed separately. (See <a class="local">'Perform supplemental procedures'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Associated varicosities that were not treated at the time of RFA should become less noticeable but may not completely disappear. Additional treatment (eg, phlebectomy, sclerotherapy) may be required to achieve the desired cosmetic result [<a href="#rid15">15,16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other risks of the procedure include bleeding, infection, phlebitis, endovenous heat-induced thrombosis (EHIT), deep venous thrombosis, and cutaneous nerve injury. (See <a class="local">'Complications'</a> below.)</p><p></p><p>Alternatives to RFA include no therapy, compression therapy, sclerotherapy, laser ablation, chemical ablation, mechanochemical ablation, or surgical removal of refluxing superficial veins. (See  <a class="medical medical_review" href="/d/html/8206.html" rel="external">"Injection sclerotherapy techniques for the treatment of telangiectasias, reticular veins, and small varicose veins"</a> and  <a class="medical medical_review" href="/d/html/15198.html" rel="external">"Techniques for endovenous laser ablation for the treatment of lower extremity chronic venous disease"</a> and  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Intervention for axial vein reflux'</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">PATIENT PREPARATION</span><span class="headingEndMark"> — </span>The evaluation of the patient includes a careful history and physical exam and noninvasive vascular laboratory studies. A venous duplex ultrasound of the affected lower extremity should evaluate the deep veins, great saphenous vein, accessory saphenous veins, if present, and small saphenous vein for patency as well as for reflux. The clinical evaluation of lower extremity chronic venous insufficiency is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease"</a> and  <a class="medical medical_review" href="/d/html/8196.html" rel="external">"Diagnostic evaluation of lower extremity chronic venous disease"</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Antithrombotic therapies</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">Aspirin</a>, antiplatelet agents, and nonsteroidal anti-inflammatory drugs are sometimes discontinued to limit postoperative bruising. However, when these medications are continued, the success of the vein closure has not been affected.</p><p>The need for therapeutic medical anticoagulation is not a contraindication to endovenous ablation. Endovenous ablation can be undertaken safely with successful outcomes in fully anticoagulated patients [<a href="#rid17">17-19</a>]. Alternatively, <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a> may also be temporarily discontinued or bridging anticoagulation initiated. (See  <a class="medical medical_review" href="/d/html/1312.html" rel="external">"Perioperative management of patients receiving anticoagulants"</a>.)</p><p>Radiofrequency ablation (RFA) in the face of direct oral anticoagulants (DOACs) has not been studied, but we would similarly expect no significant alterations in vein closure rates. </p><p class="headingAnchor" id="H11"><span class="h2">Prophylactic antibiotics</span><span class="headingEndMark"> — </span>Prophylactic antibiotics are generally not necessary. However, if RFA is combined with vein excisions, particularly in those with a higher risk for surgical site infection due to a risk for hematoma formation (eg, obese patient), antimicrobial prophylaxis may be elected even though these are clean cases [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/4043.html" rel="external">"Antimicrobial prophylaxis for prevention of surgical site infection in adults"</a>.) </p><p class="headingAnchor" id="H12"><span class="h2">Thromboprophylaxis</span><span class="headingEndMark"> — </span>Thromboprophylaxis is generally not administered prior to RFA.</p><p>However, patients with a known thrombophilia or at high risk for venous thromboembolism should receive periprocedural thromboprophylaxis according to their risk. (See  <a class="medical medical_review" href="/d/html/1339.html" rel="external">"Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"</a>.)</p><p>Periprocedural prophylactic anticoagulation (eg, low-molecular-weight heparin, <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a>, DOACs) also does not appear to affect the success of vein closure [<a href="#rid17">17</a>]. </p><p class="headingAnchor" id="H16"><span class="h2">Vein mapping/marking</span><span class="headingEndMark"> — </span>Prior to the procedure, the veins to be ablated are evaluated and mapped (ie, marked with indelible ink) with duplex ultrasound to confirm the presence of reflux and to identify vein size and depth, any large perforator veins, any existing superficial or deep venous thrombosis, or any significant anatomic variations (eg, duplication, low or high entrance of the vein into the deep venous system) [<a href="#rid21">21</a>]. (See <a class="local">'Anatomy'</a> above.)</p><p class="headingAnchor" id="H2603280477"><span class="h2">Scheduled follow-up</span><span class="headingEndMark"> — </span>A prescheduled appointment should be made for two to three days following the procedure for clinical examination and duplex ultrasound to rule out deep vein thrombosis. (See <a class="local">'Postoperative duplex ultrasound'</a> below and <a class="local">'Endovenous heat-induced thrombus'</a> below and <a class="local">'Deep venous thrombosis'</a> below.) </p><p class="headingAnchor" id="H470250255"><span class="h1">RADIOFREQUENCY DEVICES</span><span class="headingEndMark"> — </span>Radiofrequency ablation (RFA) gained early attention in the 1990s for the treatment of tumors but subsequently achieved wider application to treat other conditions (eg, cardiac dysrhythmias, Barrett's esophagus), including venous disease. RFA devices create a focal closed-loop high-frequency (in the radio range of frequencies, 300 kHz to 1 MHz) alternating current that is transmitted through an electrode. The resultant energy heats the vein wall adjacent the probe to a prespecified temperature, ultimately inducing thermal damage to the vein wall endothelium [<a href="#rid22">22,23</a>].</p><p>The first radiofrequency device (ie, ClosureFast) was approved for use in the United States in March 1999. First-generation devices were slow to use and had high recanalization rates. However, later modifications improved their effectiveness. The early RFA catheters (VNUS Closure, ClosureFAST) were available in two sizes and introduced through a 6 or 8 French sheath. The tip was heated to 85 or 90 degrees Celsius, and then the catheter was pulled back slowly (1 to 2 mm per second), maintaining a constant temperature to effect closure of the vein. These catheters are no longer available. </p><p>Venefit is the successor to these early devices and is the only device approved for RFA of the saphenous veins in the United States. Other radiofrequency devices (EVRF, VeinClear) are available in the United Kingdom and Europe. Once the vein has been accessed, the radiofrequency catheter (65 or 100 cm length) is introduced into the vein using a 7 French sheath. Venefit heats to 120 degrees Celsius; the energy is delivered through either a 3 or 7 cm catheter segment over 20 second intervals. The catheter is withdrawn in a series of 3 or 7 cm steps with the number of steps depending upon the length of the vein being treated; pullback times are generally faster compared with the original catheter.</p><p>Specialized catheters that are designed to treat perforator veins (ClosureRFS stylet, RFiTT) are shorter and have smaller catheter diameters. They are introduced through a sheath or by direct puncture [<a href="#rid17">17,24-27</a>]. </p><p class="headingAnchor" id="H17"><span class="h1">PROCEDURE</span><span class="headingEndMark"> — </span>Radiofrequency ablation (RFA) can be performed in the office setting (appropriately equipped operative suite) or ambulatory surgery center under sterile conditions. Although some surgeons will perform bilateral saphenous venous ablation in a single session, we prefer not to perform bilateral procedures due to increased postoperative pain and discomfort that might impair ambulation. </p><p>The procedure is typically performed with local anesthesia with or without oral or intravenous sedation, but rarely, general anesthesia may be appropriate depending on patient and/or surgeon preference, mostly due to <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> allergy or extreme patient anxiety. </p><p>An oral anxiolytic can be given approximately one hour prior to the procedure to help the patient relax. (See  <a class="medical medical_review" href="/d/html/16851.html" rel="external">"Acute procedural anxiety and specific phobia of clinical procedures in adults: Treatment overview", section on 'Benzodiazepines as first-line medication'</a>.)</p><p class="headingAnchor" id="H18"><span class="h2">Preparation</span></p><p class="headingAnchor" id="H3107736"><span class="h3">Equipment</span></p><p class="bulletIndent1"><span class="glyph">●</span>Duplex ultrasound machine.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endovenous device: Check the machine for proper functioning; calibrate if necessary.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Roller pump for tumescent anesthesia (eg, Klein pump).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Table with Trendelenburg and reverse Trendelenburg positions.</p><p></p><p class="headingAnchor" id="H3107753"><span class="h3">Medications</span></p><p class="bulletIndent1"><span class="glyph">●</span>Local anesthetic for puncture sites: 1% <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tumescent anesthetic: The tumescent anesthetic mixture (<a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>, <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a>, and bicarbonate) should be mixed just prior to the procedure [<a href="#rid28">28,29</a>]. Cold saline solution may be an alternative for patients with allergy to local anesthesia or who are at risk for toxicity (eg, impaired liver function) [<a href="#rid30">30</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>EMLA: Topical eutectic mixture of local anesthetics (EMLA) is useful for reducing pain associated with various types of medication injection including local anesthetic. A trial randomly assigned 62 patients undergoing RFA to receive EMLA two to three hours before tumescent injection or no EMLA [<a href="#rid31">31</a>]. Patients who received EMLA reported lower pain scores at the completion of tumescent anesthesia, but not at later time points (at the end of RFA, at discharge). Patients also reported less pain during needle puncture at EMLA pretreated areas compared with non-pretreated areas. Complication rates were similar between the groups. An earlier trial did not report improved pain scores; however, the duration of EMLA application was much shorter (20 minutes before the procedure), and it is likely the EMLA absorption was not complete. Given that EMLA does not add significantly to the cost of the procedure, we suggest pretreatment when EMLA is available. In our experience, it should be applied at least 30 minutes before the procedure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">Saline</a> (0.9%) for irrigation.</p><p></p><p class="headingAnchor" id="H3107760"><span class="h3">Materials</span></p><p class="bulletIndent1"><span class="glyph">●</span>Preparation materials: Skin antiseptic, sterile gloves.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Draping materials: Sterile drapes, bag for foot.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Roller pump tubing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Echogenic 21 gauge micropuncture needle.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>10 mL syringe with 16 to 20 gauge needle to draw up anesthetic, 27 to 30 gauge needle to inject.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Catheter sheath kit: 0.035" wire, dilator/sheath (7 French) flushed with <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>. Micropuncture sheath kit: 0.018" micropuncture wire, dilator/sheath (5 French), flushed with heparinized saline, as needed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Glidewire (0.018", 260 cm length). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Wound dressing: Self-adhesive strips, or transparent film dressing. </p><p></p><p class="headingAnchor" id="H19"><span class="h2">General technique</span><span class="headingEndMark"> — </span>RFA is performed according to the device manufacturer's instructions for use (ie, IFU). The general technique is described below. </p><p>Following sterile preparation of the lower extremity, the patient is placed in reverse Trendelenburg position to facilitate identification of the veins for sheath placement.</p><p class="headingAnchor" id="H3519254585"><span class="h3">Place the device sheath</span><span class="headingEndMark"> — </span>After anesthetizing the skin, with ultrasound guidance, an echogenic needle is used to access the chosen vein with single wall puncture, and the dilator/sheath combination is placed using the modified Seldinger technique. The inner dilator of the sheath is removed and the position checked with ultrasound. Blood return is confirmed prior to introduction of the catheter through the sheath. On occasion, the vein is unable to be accessed percutaneously. In this case, the needle is withdrawn and pressure is applied to control bleeding, as needed. Percutaneous access can be reattempted, by moving more proximally, or access can be achieved by performing a small cutdown and introducing the sheath directly into the vein  (<a class="graphic graphic_figure graphicRef51805" href="/d/graphic/51805.html" rel="external">figure 7</a>). </p><p class="headingAnchor" id="H1501237102"><span class="h3">Position the catheter</span><span class="headingEndMark"> — </span>The ultrasound probe is placed at the proximal extent of the planned ablation (eg, saphenofemoral or saphenopopliteal junction), and the radiofrequency catheter is placed through the sheath. The catheter often advances through the vein with ease; however, tortuosity or the presence of large perforator veins may necessitate the need for a guidewire. If needed, a long, floppy wire is placed through the sheath and advanced to the proximal vein under ultrasound guidance. Once the position of the wire is confirmed, the catheter is passed over the guidewire and positioned in the proximal vein, and the wire is removed. The patient is then placed in Trendelenburg position to empty the vein. The tip of the catheter is positioned at least 2.5 cm below the saphenofemoral or saphenopopliteal junction [<a href="#rid32">32</a>]. (See <a class="local">'Great saphenous vein'</a> below and <a class="local">'Small saphenous vein'</a> below.)</p><p class="headingAnchor" id="H1241365258"><span class="h3">Instill tumescent anesthesia</span><span class="headingEndMark"> — </span>Under ultrasound guidance, tumescent anesthesia is instilled into the perivenous tissue through a series of punctures along the target vein to completely envelop the vessel in tumescence. The tumescent anesthesia limits heat transfer to tissues beyond the vein, anesthetizes these tissues to decrease pain, and causes venoconstriction, which places the vein in close apposition to the ablation catheter, which is critical for closure of the vein. The use of an echogenic micropuncture/spinal needle and ultrasound facilitates tumescent needle placement, and a motorized pump may help lessen pain during delivery of tumescent anesthesia into the saphenous sheath. </p><p class="headingAnchor" id="H462003100"><span class="h3">Ablate the vein</span><span class="headingEndMark"> — </span>The position of the tip of the catheter is reevaluated with ultrasound since the installation of tumescent anesthesia tends to straighten the vein and can push the tip of the catheter cephalad. Venous ablation is carried out according to the manufacturer's instructions for use (ie, IFU) for the type of catheter chosen. The device is activated, transferring energy to the vein wall, resulting in immediate intimal loss and subsequent thrombosis as the probe is sequentially withdrawn. Vein wall thickening, inflammatory change, and, ultimately, fibrotic closure of the vein occurs with time analogous to that seen with laser ablation [<a href="#rid33">33</a>]. Compression of the vein (with ultrasound) during the ablation procedure is commonly performed to assure vein wall contact with the device and to maintain a correct level of electrical impedance.</p><p class="headingAnchor" id="H355938321"><span class="h3">Perform completion ultrasound</span><span class="headingEndMark"> — </span>A completion ultrasound is performed to evaluate closure of the vein. Following RFA, the treated vein has thickened walls (ie, appears as a hyperechoic doughnut) with thrombus in the lumen and no identifiable venous flow. The junction of the treated vein with the deep venous system is also imaged to evaluate for the presence of thrombus. The proximal vein at the junction should be compressible and hypoechoic and without the presence of any intraluminal debris, which would appear hyperechoic. (See <a class="local">'EHIT treatment and follow-up'</a> below and <a class="local">'Deep venous thrombosis'</a> below.)</p><p class="headingAnchor" id="H4188930582"><span class="h3">Perform supplemental procedures</span><span class="headingEndMark"> — </span>Following successful closure of the targeted veins, the extremity is evaluated for any significant residual veins. For small veins (&lt;6 mm), supplemental procedures may be delayed as many of these will reduce in size over time. However, larger veins and those located on the thigh are less likely to respond to elimination of reflux, and we prefer to manage these concurrently with the ablation procedure. (See  <a class="medical medical_review" href="/d/html/8206.html" rel="external">"Injection sclerotherapy techniques for the treatment of telangiectasias, reticular veins, and small varicose veins"</a> and  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Ambulatory phlebectomy'</a> and  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Treatment timing'</a>.)</p><p class="headingAnchor" id="H20"><span class="h2">Anatomic considerations</span><span class="headingEndMark"> — </span>The technical aspects of the RFA procedure vary with the anatomic site. Venous anatomy is described above. (See <a class="local">'Anatomy'</a> above.) </p><p class="headingAnchor" id="H32084778"><span class="h3">Large veins</span><span class="headingEndMark"> — </span>Very large diameter at the saphenofemoral junction (&gt;20 mm) likely represents venous aneurysm and is best treated with high ligation and vein resection prior to ablation of the more distal incompetent vein. (See <a class="local">'Relative contraindications'</a> above.)</p><p>Veins with a diameter greater than 8 to 10 mm may have a higher risk of nonclosure or thrombotic complications (eg, deep vein thrombosis, endovenous heat-induced thrombus) [<a href="#rid12">12-14</a>], but successful closure of veins with larger diameters has been reported [<a href="#rid23">23,34</a>]. (See <a class="local">'Endovenous heat-induced thrombus'</a> below and <a class="local">'Complications'</a> below.)</p><p>With alterations in technique, including providing additional tumescent and compression, double or triple heating the segment, and increasing the linear energy density (Joules/cm), larger veins can be managed safely [<a href="#rid23">23</a>]. In a retrospective review that evaluated treatment of smaller veins (4 to 11 mm) compared with larger veins (12 to 21 mm), the rates of closure at 1, 6, and 12 months were similar [<a href="#rid35">35</a>]. There was no difference in the rate of adverse events between the groups. (See <a class="local">'General technique'</a> above and <a class="local">'Saphenous ablation'</a> below.)</p><p class="headingAnchor" id="H95371673"><span class="h3">Specific anatomic sites</span></p><p class="headingAnchor" id="H3735796042"><span class="h4">Great saphenous vein</span><span class="headingEndMark"> — </span>Great saphenous venous ablation is performed with the catheter tip positioned at least 2.5 cm below the saphenofemoral junction. The optimal closure level is below the origin of the superficial epigastric vein to preserve flow into the proximal great saphenous vein [<a href="#rid12">12</a>]. The anatomy of the veins in the region of the saphenofemoral junction can be quite variable  (<a class="graphic graphic_figure graphicRef113245" href="/d/graphic/113245.html" rel="external">figure 2</a>), and identification of the tip of the catheter using ultrasound is essential. </p><p>The sheath may safely be placed in the great saphenous vein in the proximal calf. Treatment in the proximal below-knee great saphenous vein often improves long-term outcomes when there is reflux in this segment, but care must be taken to avoid excessive heating of the great saphenous vein around the knee due to the proximity of the saphenous nerve  (<a class="graphic graphic_figure graphicRef59888" href="/d/graphic/59888.html" rel="external">figure 8</a>) [<a href="#rid36">36</a>]. (See <a class="local">'Saphenous nerve'</a> above and <a class="local">'Nerve injury'</a> below.)</p><p class="headingAnchor" id="H3952030524"><span class="h4">Accessory saphenous vein</span><span class="headingEndMark"> — </span>Accessory saphenous venous ablation is performed in a similar manner as the great saphenous vein, as described above. (See <a class="local">'General technique'</a> above.)</p><p>Compared with the great and small saphenous veins, the accessory saphenous veins have a shorter straight segment, and the remainder is tortuous. The straight portion of the vein can be ablated with the radiofrequency device and the more tortuous segments subsequently managed with phlebectomy. The catheter tip is positioned at least 2.5 cm below the saphenofemoral junction. Adequate tumescent anesthesia is important since these veins can be more superficial and often do not have a well-defined saphenous sheath. </p><p class="headingAnchor" id="H1320851091"><span class="h4">Small saphenous vein</span><span class="headingEndMark"> — </span>For small saphenous venous ablation, the sheath is placed at the lower border of the gastrocnemius muscle, and not below this level, to avoid thermal injury to the medial cutaneous sural nerve  (<a class="graphic graphic_figure graphicRef62917" href="/d/graphic/62917.html" rel="external">figure 6</a>) [<a href="#rid7">7</a>]. The catheter tip is positioned at the fascial curve. Tumescent anesthesia is instilled, as with the great saphenous vein, and the procedure is performed with the patient in Trendelenburg position. Instillation of the tumescent anesthesia is extremely important in small saphenous venous ablation because of the proximity of the vein to the sural nerve. (See <a class="local">'General technique'</a> above and <a class="local">'Sural nerve'</a> above and <a class="local">'Nerve injury'</a> below.) </p><p></p><p>The anatomy of the saphenopopliteal junction (SPJ) is highly variable  (<a class="graphic graphic_figure graphicRef82053" href="/d/graphic/82053.html" rel="external">figure 3</a>) [<a href="#rid4">4,7</a>]. If the SPJ is high, care should be taken to identify the location of the tibial nerve relative to the SPJ, and to use tumescent anesthesia to push it away from the vein  (<a class="graphic graphic_figure graphicRef119033" href="/d/graphic/119033.html" rel="external">figure 9</a>). </p><p class="headingAnchor" id="H4109060922"><span class="h4">Perforator veins</span><span class="headingEndMark"> — </span>Incompetent perforator veins can also be closed with RFA but require a specialized stylet [<a href="#rid24">24,25</a>]. The procedure is performed with ultrasound guidance. The perforator is accessed either directly or with the Seldinger technique. The catheter is positioned 1 to 2 mm below the deep fascia but at least 5 mm superficial to the deep veins to avoid thermal injury to the deep veins. The tumescent or local anesthesia is administered both above and below the fascia while the catheter is held in place. With the patient in Trendelenburg position, the ablation is performed according to the manufacturer's instructions for use (ie, IFU) for the chosen device. The catheter is removed and completion ultrasound performed. </p><p class="headingAnchor" id="H21"><span class="h1">FOLLOW-UP CARE</span></p><p class="headingAnchor" id="H22"><span class="h2">Pain management</span><span class="headingEndMark"> — </span>Nonsteroidal anti-inflammatory drugs (NSAIDs) are generally used in all patients without a contraindication to minimize a significant phlebitic reaction. Patients who have a contraindication to nonsteroidal anti-inflammatory medications may require stronger analgesics (eg, <a class="drug drug_general" data-topicid="9291" href="/d/drug information/9291.html" rel="external">codeine</a>) for a short period of time. An ice pack can also be applied to the affected areas for comfort and to decrease inflammation. (See  <a class="medical medical_review" href="/d/html/7993.html" rel="external">"NSAIDs: Therapeutic use and variability of response in adults"</a> and  <a class="medical medical_review" href="/d/html/133187.html" rel="external">"Nonopioid pharmacotherapy for acute pain in adults", section on 'Nonsteroidal anti-inflammatory drugs'</a>.)</p><p class="headingAnchor" id="H23"><span class="h2">Patient instructions</span><span class="headingEndMark"> — </span>Postoperatively, we instruct patients to:</p><p class="bulletIndent1"><span class="glyph">●</span>Ambulate normally. Make an effort in the first postoperative day to walk every hour before bedtime and then daily for 15 to 30 minutes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Avoid prolonged standing and sitting; when seated, elevate the treated extremity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Avoid heavy lifting and exercise for two weeks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Resume normal job duties within three to four days; however, jobs requiring prolonged standing/heavy lifting may require additional time off.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maintain the postoperative dressing and elastic bandages/compression stockings until the postoperative duplex examination, which should occur within two to three days following the procedure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reinforce any areas of bleeding that occur through the dressing, but call their clinician if excessive bleeding occurs. This is more commonly associated with vein excisions performed at the same time as the endovenous ablation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Wear their bandages/compression stockings continuously for the first 48 hours, and if concurrent phlebectomies have been performed, continue to wear them during the day for the next two weeks. While the form of compression and duration of treatment remain debated, the downsides of compression are minimal [<a href="#rid37">37-39</a>]. (See <a class="local">'Post-procedure compression'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Not be alarmed at the development of a pulling/tugging sensation along the course of the treated vein. This is due to the scarring of the vein, which adheres it to the surrounding tissues. Gentle stretching exercises may help.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Call their clinician if they notice numbness, tingling, coolness, or discoloration of the toes of the treated extremity. The postoperative compression bandages/stockings may be too tight and may need to be removed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Call their clinician promptly if they experience swelling or excessive pain not relieved with the prescribed pain medications because this may be a symptom of deep vein thrombosis.</p><p></p><p class="headingAnchor" id="H1635530953"><span class="h2">Post-procedure compression</span><span class="headingEndMark"> — </span>Our approach is to have the patient wear compression stockings (eg, thigh-high or pantyhose) for the first two days following RFA, and then during the daytime for at least two weeks if concurrent phlebectomies have been performed. Patients are prescribed 15 to 20 mmHg or a higher level of compression  (<a class="graphic graphic_table graphicRef74574" href="/d/graphic/74574.html" rel="external">table 1</a>), which they may have already been using prior to the scheduled procedure. (See  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Response to initial measures'</a>.)</p><p>The need for and, when used, the optimal duration of compression following RFA for saphenous reflux (in the absence of venous ulceration) is debated [<a href="#rid37">37-42</a>]. A systematic review identified four trials comparing compression therapy with no compression therapy after RFA [<a href="#rid40">40</a>]. In a meta-analysis of three trials that used a visual analog scale to assess pain (552 patients), while postoperative scores were lower in the compression group, the difference did not appear to be clinically significant. Also, among trials that evaluated other outcomes, occlusion rates, complication rates, and Aberdeen Varicose Vein Questionnaire scores were similar between the groups. </p><p>If a patient with mild arterial disease is a candidate for and is treated with an endovenous procedure, eccentric rather than circumferential compression should be used postprocedure. Eccentric compression involves placing a bolster over the treated vein and taping it into place. A light bandage can be used to hold the bolster in place, if needed. </p><p class="headingAnchor" id="H3157317912"><span class="h2">Resumption of normal activities</span><span class="headingEndMark"> — </span>The low incidence of adverse effects and complications with RFA results in a significantly lower number of days to return to normal activities and work compared with vein stripping (1.5 versus 3.9 days, 4.7 versus 12.4 days) [<a href="#rid43">43,44</a>]. </p><p>Multiple randomized trials have also shown that immediate postoperative quality-of-life measures (pain, ecchymosis, tenderness) are significantly better following treatment of the saphenous vein using RFA compared with laser methods [<a href="#rid43">43-48</a>]. However, it is important to note that many of these studies used lower-wavelength lasers, which are used less frequently compared with the higher-wavelength lasers. Higher laser wavelengths (eg, 1470 nm) have been associated with fewer postoperative symptoms [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/d/html/15233.html" rel="external">"Comparison of methods for endovenous ablation for chronic venous disease", section on 'Quality of life'</a>.)</p><p class="headingAnchor" id="H24"><span class="h2">Postoperative duplex ultrasound</span><span class="headingEndMark"> — </span>A follow-up duplex ultrasound is most often performed within two to three days of the procedure [<a href="#rid9">9,50,51</a>]. The main purpose of the postoperative duplex study is to carefully evaluate the proximal extent of the ablated vein for thrombus and to determine whether any thrombus extends into the deep veins. </p><p>The most common duplex finding following ablation of the great saphenous vein in the groin is an open, competent saphenofemoral junction with less than 5 cm of patent terminal vein segment and vein wall thickening and thrombus in the distal vein. Prograde flow is seen from the saphenous tributaries into the proximal saphenous vein [<a href="#rid52">52,53</a>]. Thrombus may also be identified at the saphenofemoral/saphenopopliteal junction, extending up to, but not into, the deep vein. If the initial ultrasound demonstrates no thrombus in the deep vein, repeat ultrasound is not required unless the patient develops new symptoms. </p><p>When patients treated with RFA for advanced venous disease (edema, skin changes, venous ulceration) develop recurrence, we reevaluate them with duplex ultrasound to identify any residual/recurrent superficial venous reflux. In the absence of significant superficial venous reflux, we consider obtaining a computed tomography (CT) venogram to evaluate for obstruction of the iliac veins or inferior vena cava. (See  <a class="medical medical_review" href="/d/html/15223.html" rel="external">"Overview of iliocaval venous obstruction"</a>.)</p><p class="headingAnchor" id="H326343812"><span class="h3">Endovenous heat-induced thrombus</span><span class="headingEndMark"> — </span>Although thrombus extension from the saphenous vein into the proximal deep vein cephalad to the level of the ablation is uncommon, it can occur and has been termed endovenous heat-induced thrombus (EHIT) [<a href="#rid54">54</a>]. The incidence of EHIT after RFA is low, ranging between 1 and 3 percent, and the incidence appears to be similar to that following endovenous laser ablation (EVLA) [<a href="#rid55">55-58</a>]. Repeat duplex examination is usually performed within a week to evaluate for any propagation. Patients identified to have occlusive common femoral thrombus are treated accordingly. (See <a class="local">'Deep venous thrombosis'</a> below.) </p><p>In an early review of 500 patients, a great saphenous vein diameter &gt;8 mm at the level of the saphenofemoral junction, or a history of deep vein thrombosis, increased the risk for thrombus extension into the femoral vein following venous ablation (ie, EHIT) [<a href="#rid12">12</a>]. A later review of 312 patients undergoing great saphenous venous ablation (various methods) also reported an increased incidence of EHIT for a large proximal great saphenous vein diameter [<a href="#rid57">57</a>]. Patients who developed EHIT had a mean great saphenous vein diameter of 13.1 mm, and 11 percent had saphenofemoral junction incompetence. By comparison, those who did not develop EHIT had a mean diameter of 8.4 mm, and only 0.44 percent had saphenofemoral junction incompetence. A review of over 4000 ablation treatments (RFA or EVLA) supports the notion that increasing the distance of the laser tip from the saphenofemoral junction reduces the risk of EHIT [<a href="#rid32">32</a>]. In this study, there was a trend toward a decreased incidence of EHIT when the tip of the catheter was &gt;2.5 cm compared with 2 cm from the junction (2.3 versus 1.3 percent). However, a separate review that included 519 great or anterior saphenous venous ablation procedures (RFA or EVLA) did not identify vein diameter, short distance of the catheter tip to saphenofemoral junction, type of endovenous ablation (RFA versus EVLA), concomitant treatments (sclerotherapy, phlebectomy), or perioperative anticoagulation as risk factors for EHIT [<a href="#rid56">56</a>]. Rather, on multivariate analysis, only male gender and Caprini thrombosis risk factor assessment score  (<a class="graphic graphic_table graphicRef83739" href="/d/graphic/83739.html" rel="external">table 2</a>) were significant risk factors. </p><p class="headingAnchor" id="H1173303430"><span class="h4">Classification</span><span class="headingEndMark"> — </span>A classification of EHIT has been proposed to provide an accurate description of the level of proximal great saphenous thrombus for the purpose of guiding clinical therapy and further research [<a href="#rid12">12</a>]. This classification scheme, and a similar but simplified classification that may be more clinically useful [<a href="#rid59">59,60</a>], are described and illustrated in the figures  (<a class="graphic graphic_figure graphicRef130659 graphicRef111960 graphicRef112355" href="/d/graphic/130659.html" rel="external">figure 10A-C</a>). </p><p class="headingAnchor" id="H3375556637"><span class="h4">EHIT treatment and follow-up</span><span class="headingEndMark"> — </span>Patients diagnosed with thrombus within the deep veins are anticoagulated (Lawrence: Level V, VI; Kabnick: Class 3, 4)  (<a class="graphic graphic_figure graphicRef112355 graphicRef111960" href="/d/graphic/112355.html" rel="external">figure 10B-C</a>), and a follow-up duplex ultrasound should be obtained within 7 to 10 days. In some cases of EHIT following great saphenous venous ablation, thrombus contraction occurs and thrombus is no longer apparent within the common femoral vein, at which point anticoagulation may be discontinued. </p><p>Persistence of thrombus in the common femoral vein (ie, deep vein thrombosis) is managed according to standard protocols. (See  <a class="medical medical_review" href="/d/html/1362.html" rel="external">"Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)"</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">LOCAL ADVERSE REACTIONS</span><span class="headingEndMark"> — </span>Significant pain is not typical following radiofrequency ablation (RFA) even when vein excisions are performed concurrently, though some patients may have a mild phlebitic reaction. Rupture of the treated vein with ecchymosis or hematoma formation is uncommon. Skin burns, hyperpigmentation, and telangiectatic matting are also infrequent with this technique (&lt;1 percent).</p><p>A mild phlebitic/inflammatory reaction is anticipated along the course of the ablated vein, but retrograde extension into neighboring tributaries may cause pain and inflammation in regions that appear remote from the ablation procedure [<a href="#rid61">61</a>]. The reported incidence of this symptomatic phlebitic reaction following RFA ranges from 0 to 5.2 percent and does not appear to be related to whether or not concomitant phlebectomy was performed [<a href="#rid54">54,62-66</a>]. Higher rates have been reported in studies that have included concomitant phlebectomy [<a href="#rid67">67</a>].</p><p>This phlebitic reaction is managed conservatively and can be ameliorated by preemptively using nonsteroidal anti-inflammatory drugs (NSAIDs). Thrombosed vein segments that are painful and tender postprocedure can also be treated with cold compresses. (See <a class="local">'Pain management'</a> above.)</p><p>More significant signs or symptoms of pain or edema warrant ultrasound examination to evaluate for the presence of proximal clot extension. (See <a class="local">'Postoperative duplex ultrasound'</a> above.)</p><p class="headingAnchor" id="H26"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Complications associated with radiofrequency ablation (RFA) primarily include cutaneous nerve injury and deep venous thrombosis. The development of an arteriovenous (AV) fistula has been reported following perforator ablation [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H28"><span class="h2">Nerve injury</span><span class="headingEndMark"> — </span>Sensory abnormalities are reported in 0 to 22 percent of patients following ablation of the great saphenous vein and are usually transient. </p><p>Saphenous nerve injury may be more likely when the sheath is placed below the level of the midcalf, due to the adherence of the saphenous nerve to the saphenous vein in the distal third of the calf  (<a class="graphic graphic_figure graphicRef59888" href="/d/graphic/59888.html" rel="external">figure 8</a>) [<a href="#rid6">6</a>]. </p><p>Small saphenous venous ablation may be associated with sural nerve paresthesias  (<a class="graphic graphic_figure graphicRef62917" href="/d/graphic/62917.html" rel="external">figure 6</a>). Injury to the common fibular (peroneal) nerve has also been reported but is more likely related to concurrent vein excisions in proximity of the lateral fibular head where this nerve becomes extremely superficial  (<a class="graphic graphic_figure graphicRef76717" href="/d/graphic/76717.html" rel="external">figure 11</a>) [<a href="#rid68">68</a>]. Tibial nerve injury can also occur, particularly if the saphenopopliteal junction is high  (<a class="graphic graphic_figure graphicRef119033" href="/d/graphic/119033.html" rel="external">figure 9</a>) [<a href="#rid7">7,68</a>]. </p><p class="headingAnchor" id="H29"><span class="h2">Deep venous thrombosis</span><span class="headingEndMark"> — </span>Deep vein thrombosis and pulmonary embolism have been reported following RFA; however, at experienced centers, the risk is &lt;1 percent [<a href="#rid50">50,55,69,70</a>]. Direct thermal injury to the deep veins can occur due to catheter malposition, but the majority of thromboses occurring following RFA appear to be related to extension of clot from thrombus induced in the ablated vein, a mechanism referred to as endovenous heat-induced thrombus (EHIT), which generally has a benign course. This is discussed above. (See <a class="local">'Endovenous heat-induced thrombus'</a> above.)</p><p>Patients with occlusive thrombus in the common femoral vein or femoral vein are treated accordingly. (See  <a class="medical medical_review" href="/d/html/1362.html" rel="external">"Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)"</a>.)</p><p class="headingAnchor" id="H32"><span class="h2">Other complications</span><span class="headingEndMark"> — </span>Although uncommon, the loss of radiographic guidewires/sheath components into the circulation has been reported. Ensuring that wires are at least twice the length of the catheter/sheath into which they are introduced minimizes the likelihood of this complication.</p><p>Device components should be examined carefully after they are removed from the patient to insure their integrity. If there is any question about the possible loss of a device, radiographs should be obtained.</p><p class="headingAnchor" id="H2662270159"><span class="h1">CLOSURE RATES AND RECURRENCE</span><span class="headingEndMark"> — </span>Outcomes specific to radiofrequency ablation (RFA) are briefly reviewed below. A comparison of radiofrequency with other venous ablation techniques is provided separately. (See  <a class="medical medical_review" href="/d/html/15233.html" rel="external">"Comparison of methods for endovenous ablation for chronic venous disease"</a>.)</p><p>Closure rates with RFA have improved with operator experience and later-generation technologies. Immediate closure rates are higher for the saphenous veins compared with perforator veins (&gt;90 versus 70 to 82 percent) [<a href="#rid25">25,54,71-75</a>].</p><p class="headingAnchor" id="H34"><span class="h2">Saphenous ablation</span><span class="headingEndMark"> — </span>In two meta-analyses evaluating anatomic vein closure, immediate closure rates were between 89 and 94 percent for great saphenous venous ablation using earlier continuous pullback catheters [<a href="#rid74">74,76</a>]. Alterations in closure technique, increasing probe temperature, and increased ablation time have resulted in immediate occlusion rates as high as 99.6 percent; however, long-term data are not available for later-generation devices [<a href="#rid77">77,78</a>]. Immediate closure rates for the small saphenous vein are similar to those of the great saphenous vein [<a href="#rid79">79,80</a>]. </p><p>Symptoms and appearance of varicose veins as reflected by venous clinical severity scales (VCSS) are also significantly improved following RFA of the saphenous vein [<a href="#rid43">43,71,81</a>]. In a retrospective review, the VCSS in 256 extremities improved (ie, less severe) from 3.9±2.1 before RFA of the great saphenous vein to 0.9±1.5 at three months, and the VCSS was maintained at &lt;1.0 for up to two years [<a href="#rid81">81</a>].</p><p>Following initially successful ablation, duplex ultrasound may later show procedural failure. In the meta-analyses, reopening of the previously occluded vein occurred in 15 to 19 percent of veins at three years and in 26 to 30 percent of veins at three- to five-year follow-up [<a href="#rid74">74,76,82</a>]. In spite of this, some of these patients may still have clinical improvement as reflected that is maintained long term [<a href="#rid71">71,83</a>]. Anatomic failure is a useful term to distinguish these patients from those with clinical failure (ie, recurrent clinical symptoms and/or varicose veins). Anatomic failure is classified as type I, II, or III, depending on the timing of failure and etiology  (<a class="graphic graphic_table graphicRef121325" href="/d/graphic/121325.html" rel="external">table 3</a>) [<a href="#rid34">34</a>]:</p><p>Following RFA, varicose vein recurrence can occur in up to one third of patients, which was similar to other ablation methods in a meta-analysis comparing RFA, saphenous stripping, and laser ablation [<a href="#rid84">84</a>]. </p><p class="headingAnchor" id="H35"><span class="h2">Perforator ablation</span><span class="headingEndMark"> — </span>Minimally invasive techniques including RFA are associated with fewer complications compared with surgical management of refluxing perforators (ie, subfascial endoscopic of perforator surgery [SEPS]) [<a href="#rid85">85-87</a>]. Clinical trials comparing RFA with other therapies for the management of venous ulceration and standardization of the radiofrequency perforator ablation technique are needed [<a href="#rid24">24,88</a>]. (See  <a class="medical medical_review" href="/d/html/15233.html" rel="external">"Comparison of methods for endovenous ablation for chronic venous disease", section on 'Ulcer healing'</a>.)</p><p>Immediate occlusion of perforator veins following RFA occurs in 70 to 82 percent of treated veins [<a href="#rid25">25,26,75</a>]. In one prospective study, at five-year follow-up, recurrent reflux developed in 19 percent of perforators previously confirmed closed [<a href="#rid24">24</a>]. Interestingly, of the total number of perforators identified with reflux, 19 percent were new [<a href="#rid24">24</a>]. In a retrospective review, RFA of perforator veins was more successful in the proximal calf and ankle regions compared with the middle and distal calf [<a href="#rid89">89</a>].</p><p>RFA reliably ablated perforator venous reflux after failed ultrasound-guided foam sclerotherapy (UGFS) [<a href="#rid17">17</a>]. Morbid obesity (body mass index &gt;50) predicted failure of perforator closure in all groups. Failure of UGFS as an initial treatment increased the success of perforator closure when thermal ablation was used as a secondary technique. </p><p class="headingAnchor" id="H2167211781"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118466.html" rel="external">"Society guideline links: Chronic venous disorders"</a>.)</p><p class="headingAnchor" id="H41"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Candidates for radiofrequency ablation (RFA), a minimally invasive thermal venous ablation technique, are patients with persistent symptoms/signs of chronic venous disease and documented venous reflux (ie, retrograde flow &gt;0.5 second duration) as a source of their symptoms. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RFA is used to primarily treat venous insufficiency of the axial veins (ie, great, small, accessory saphenous veins). Specialized probes are available for treating perforator veins. (See <a class="local">'Radiofrequency devices'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RFA devices transmit a high-frequency alternating current through an electrode that heats the vein wall, altering its intrinsic protein structure and effecting closure of the vein. (See <a class="local">'Radiofrequency devices'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RFA is performed in an office-based or ambulatory surgery setting in a stepwise fashion with local tumescent anesthetic and mild sedation, as needed. (See <a class="local">'Procedure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A follow-up duplex ultrasound is performed within two to three days of the procedure to evaluate for deep vein thrombosis and/or endovenous heat-induced thrombus (EHIT). We repeat duplex ultrasound within a week if thrombus is identified at the saphenofemoral/saphenopopliteal junction, extending up to, or into, the deep vein. (See <a class="local">'Postoperative duplex ultrasound'</a> above and <a class="local">'EHIT treatment and follow-up'</a> above and <a class="local">'Deep venous thrombosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complications following RFA are uncommon and include nerve injury and, rarely, deep vein thrombosis. (See <a class="local">'Complications'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Prakash, Kumari J, Nishanth Reddy N, et al. A review of literature along with a cadaveric study of the prevalence of the Giacomini vein (the thigh extension of the small saphenous vein) in the Indian population. Rom J Morphol Embryol 2008; 49:537.</a></li><li><a class="nounderline abstract_t">Gibson KD, Ferris BL, Polissar N, et al. Endovenous laser treatment of the small [corrected] saphenous vein: efficacy and complications. J Vasc Surg 2007; 45:795.</a></li><li><a class="nounderline abstract_t">Delis KT, Knaggs AL, Khodabakhsh P. Prevalence, anatomic patterns, valvular competence, and clinical significance of the Giacomini vein. J Vasc Surg 2004; 40:1174.</a></li><li><a class="nounderline abstract_t">Schweighofer G, Mühlberger D, Brenner E. The anatomy of the small saphenous vein: fascial and neural relations, saphenofemoral junction, and valves. J Vasc Surg 2010; 51:982.</a></li><li><a class="nounderline abstract_t">Caggiati A, Bergan JJ, Gloviczki P, et al. Nomenclature of the veins of the lower limbs: an international interdisciplinary consensus statement. J Vasc Surg 2002; 36:416.</a></li><li><a class="nounderline abstract_t">Dayan V, Cura L, Cubas S, Carriquiry G. Surgical anatomy of the saphenous nerve. Ann Thorac Surg 2008; 85:896.</a></li><li><a class="nounderline abstract_t">Kerver AL, van der Ham AC, Theeuwes HP, et al. The surgical anatomy of the small saphenous vein and adjacent nerves in relation to endovenous thermal ablation. J Vasc Surg 2012; 56:181.</a></li><li><a class="nounderline abstract_t">Rodriguez-Acevedo O, Elstner K, Zea A, et al. The sural nerve: Sonographic anatomy, variability and relation to the small saphenous vein in the setting of endovenous thermal ablation. Phlebology 2017; 32:49.</a></li><li><a class="nounderline abstract_t">Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53:2S.</a></li><li><a class="nounderline abstract_t">Enzler MA, Russell D, Schimmelpfennig J. Thermal ablation in the management of superficial thrombophlebitis. Eur J Vasc Endovasc Surg 2012; 43:726.</a></li><li><a class="nounderline abstract_t">Gradman WS. Adjunctive proximal vein ligation with endovenous obliteration of great saphenous vein reflux: does it have clinical value? Ann Vasc Surg 2007; 21:155.</a></li><li><a class="nounderline abstract_t">Lawrence PF, Chandra A, Wu M, et al. Classification of proximal endovenous closure levels and treatment algorithm. J Vasc Surg 2010; 52:388.</a></li><li><a class="nounderline abstract_t">Sufian S, Arnez A, Labropoulos N, Lakhanpal S. Incidence, progression, and risk factors for endovenous heat-induced thrombosis after radiofrequency ablation. J Vasc Surg Venous Lymphat Disord 2013; 1:159.</a></li><li><a class="nounderline abstract_t">Sermsathanasawadi N, Pitaksantayothin W, Puangpunngam N, et al. Incidence, Risk Factors, Progression, and Treatment of Endovenous Heat-Induced Thrombosis Class 2 or Greater After Endovenous Radiofrequency Ablation. Dermatol Surg 2019; 45:573.</a></li><li><a class="nounderline abstract_t">Monahan DL. Can phlebectomy be deferred in the treatment of varicose veins? J Vasc Surg 2005; 42:1145.</a></li><li><a class="nounderline abstract_t">Welch HJ. Endovenous ablation of the great saphenous vein may avert phlebectomy for branch varicose veins. J Vasc Surg 2006; 44:601.</a></li><li><a class="nounderline abstract_t">Hager ES, Washington C, Steinmetz A, et al. Factors that influence perforator vein closure rates using radiofrequency ablation, laser ablation, or foam sclerotherapy. J Vasc Surg Venous Lymphat Disord 2016; 4:51.</a></li><li><a class="nounderline abstract_t">Gabriel V, Jimenez JC, Alktaifi A, et al. Success of endovenous saphenous and perforator ablation in patients with symptomatic venous insufficiency receiving long-term warfarin therapy. Ann Vasc Surg 2012; 26:607.</a></li><li><a class="nounderline abstract_t">Sharifi M, Mehdipour M, Bay C, et al. Effect of anticoagulation on endothermal ablation of the great saphenous vein. J Vasc Surg 2011; 53:147.</a></li><li><a class="nounderline abstract_t">Venkatesan AM, Kundu S, Sacks D, et al. Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular Interventional Radiological Society of Europe and Canadian Interventional Radiology Association [corrected]. J Vasc Interv Radiol 2010; 21:1611.</a></li><li><a class="nounderline abstract_t">Pichot O, Sessa C, Chandler JG, et al. Role of duplex imaging in endovenous obliteration for primary venous insufficiency. J Endovasc Ther 2000; 7:451.</a></li><li><a class="nounderline abstract_t">Goodyear SJ, Nyamekye IK. Radiofrequency ablation of varicose veins: Best practice techniques and evidence. Phlebology 2015; 30:9.</a></li><li><a class="nounderline abstract_t">García-Madrid C, Pastor Manrique JO, Sánchez VA, Sala-Planell E. Endovenous radiofrequency ablation (venefit procedure): impact of different energy rates on great saphenous vein shrinkage. Ann Vasc Surg 2013; 27:314.</a></li><li><a class="nounderline abstract_t">Bacon JL, Dinneen AJ, Marsh P, et al. Five-year results of incompetent perforator vein closure using TRans-Luminal Occlusion of Perforator. Phlebology 2009; 24:74.</a></li><li><a class="nounderline abstract_t">Peden E, Lumsden A. Radiofrequency ablation of incompetent perforator veins. Perspect Vasc Surg Endovasc Ther 2007; 19:73.</a></li><li><a class="nounderline abstract_t">Marsh P, Price BA, Holdstock JM, Whiteley MS. One-year outcomes of radiofrequency ablation of incompetent perforator veins using the radiofrequency stylet device. Phlebology 2010; 25:79.</a></li><li><a class="nounderline abstract_t">Roth SM. Endovenous radiofrequency ablation of superficial and perforator veins. Surg Clin North Am 2007; 87:1267.</a></li><li><a class="nounderline abstract_t">Nandhra S, Wallace T, El-Sheikha J, et al. A Randomised Clinical Trial of Buffered Tumescent Local Anaesthesia During Endothermal Ablation for Superficial Venous Incompetence. Eur J Vasc Endovasc Surg 2018; 56:699.</a></li><li><a class="nounderline abstract_t">Klein JA, Jeske DR. Estimated Maximal Safe Dosages of Tumescent Lidocaine. Anesth Analg 2016; 122:1350.</a></li><li><a class="nounderline abstract_t">Chong PFS, Kumar R, Kushwaha R, et al. Technical tip: cold saline infiltration instead of local anaesthetic in endovenous laser treatment. Phlebology 2006; 21:88.</a></li><li><a class="nounderline abstract_t">Zhang YS, Chen PJ, Wan HL, et al. Reducing tumescent anesthetic injection pain by topical anesthesia pretreatment among patients undergoing endovenous radiofrequency ablation of varicose veins: A double-blind randomized controlled trial. Phlebology 2022; 37:529.</a></li><li><a class="nounderline abstract_t">Sadek M, Kabnick LS, Rockman CB, et al. Increasing ablation distance peripheral to the saphenofemoral junction may result in a diminished rate of endothermal heat-induced thrombosis. J Vasc Surg Venous Lymphat Disord 2013; 1:257.</a></li><li><a class="nounderline abstract_t">Bush RG, Shamma HN, Hammond K. Histological changes occurring after endoluminal ablation with two diode lasers (940 and 1319 nm) from acute changes to 4 months. Lasers Surg Med 2008; 40:676.</a></li><li><a class="nounderline abstract_t">Khilnani NM, Grassi CJ, Kundu S, et al. Multi-society consensus quality improvement guidelines for the treatment of lower-extremity superficial venous insufficiency with endovenous thermal ablation from the Society of Interventional Radiology, Cardiovascular Interventional Radiological Society of Europe, American College of Phlebology and Canadian Interventional Radiology Association. J Vasc Interv Radiol 2010; 21:14.</a></li><li><a class="nounderline abstract_t">Cabrero Fernandez M, Martinez Lopez I, Hernandez Mateo MM, et al. Prospective study of safety and effectiveness in the use of radiofrequency ablation for incompetent great saphenous vein ≥12 mm. J Vasc Surg Venous Lymphat Disord 2017; 5:810.</a></li><li><a class="nounderline abstract_t">Gifford SM, Kalra M, Gloviczki P, et al. Reflux in the below-knee great saphenous vein can be safely treated with endovenous ablation. J Vasc Surg Venous Lymphat Disord 2014; 2:397.</a></li><li><a class="nounderline abstract_t">Ayo D, Blumberg SN, Rockman CR, et al. Compression versus No Compression after Endovenous Ablation of the Great Saphenous Vein: A Randomized Controlled Trial. Ann Vasc Surg 2017; 38:72.</a></li><li><a class="nounderline abstract_t">Krasznai AG, Sigterman TA, Troquay S, et al. A randomised controlled trial comparing compression therapy after radiofrequency ablation for primary great saphenous vein incompetence. Phlebology 2016; 31:118.</a></li><li><a class="nounderline abstract_t">Al Shakarchi J, Wall M, Newman J, et al. The role of compression after endovenous ablation of varicose veins. J Vasc Surg Venous Lymphat Disord 2018; 6:546.</a></li><li><a class="nounderline abstract_t">Zhang D, Shi C, Zhang Y, et al. Compression versus no compression after endovenous radiofrequency ablation: A meta-analysis of randomized controlled trials. Phlebology 2022; 37:555.</a></li><li><a class="nounderline abstract_t">Pihlaja T, Mella M, Ohtonen P, et al. Recovery and patient satisfaction following radiofrequency ablation and concomitant foam sclerotherapy of varicose veins with and without compression: A randomized controlled non-inferiority trial. Phlebology 2022; 37:303.</a></li><li><a class="nounderline abstract_t">Chou JH, Chen SY, Chen YT, et al. Optimal duration of compression stocking therapy following endovenous thermal ablation for great saphenous vein insufficiency: A meta-analysis. Int J Surg 2019; 65:113.</a></li><li><a class="nounderline abstract_t">Almeida JI, Kaufman J, Göckeritz O, et al. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study). J Vasc Interv Radiol 2009; 20:752.</a></li><li><a class="nounderline abstract_t">Lurie F, Creton D, Eklof B, et al. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study). J Vasc Surg 2003; 38:207.</a></li><li><a class="nounderline abstract_t">Goode SD, Chowdhury A, Crockett M, et al. Laser and radiofrequency ablation study (LARA study): a randomised study comparing radiofrequency ablation and endovenous laser ablation (810 nm). Eur J Vasc Endovasc Surg 2010; 40:246.</a></li><li><a class="nounderline abstract_t">Shepherd AC, Gohel MS, Brown LC, et al. Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation versus laser for varicose veins. Br J Surg 2010; 97:810.</a></li><li><a class="nounderline abstract_t">Gale SS, Lee JN, Walsh ME, et al. A randomized, controlled trial of endovenous thermal ablation using the 810-nm wavelength laser and the ClosurePLUS radiofrequency ablation methods for superficial venous insufficiency of the great saphenous vein. J Vasc Surg 2010; 52:645.</a></li><li><a class="nounderline abstract_t">Nordon IM, Hinchliffe RJ, Brar R, et al. A prospective double-blind randomized controlled trial of radiofrequency versus laser treatment of the great saphenous vein in patients with varicose veins. Ann Surg 2011; 254:876.</a></li><li><a class="nounderline abstract_t">Almeida J, Mackay E, Javier J, et al. Saphenous laser ablation at 1470 nm targets the vein wall, not blood. Vasc Endovascular Surg 2009; 43:467.</a></li><li><a class="nounderline abstract_t">Mozes G, Kalra M, Carmo M, et al. Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques. J Vasc Surg 2005; 41:130.</a></li><li><a class="nounderline abstract_t">Gornik HL, Gerhard-Herman MD, Misra S, et al. ACCF/ACR/AIUM/ASE/IAC/SCAI/SCVS/SIR/SVM/SVS/SVU 2013 appropriate use criteria for peripheral vascular ultrasound and physiological testing part II: testing for venous disease and evaluation of hemodialysis access: a report of the american college of cardiology foundation appropriate use criteria task force. J Am Coll Cardiol 2013; 62:649.</a></li><li><a class="nounderline abstract_t">Pichot O, Kabnick LS, Creton D, et al. Duplex ultrasound scan findings two years after great saphenous vein radiofrequency endovenous obliteration. J Vasc Surg 2004; 39:189.</a></li><li><a class="nounderline abstract_t">Fassiadis N, Kianifard B, Holdstock JM, Whiteley MS. Ultrasound changes at the saphenofemoral junction and in the long saphenous vein during the first year after VNUS closure. Int Angiol 2002; 21:272.</a></li><li><a class="nounderline abstract_t">Puggioni A, Kalra M, Carmo M, et al. Endovenous laser therapy and radiofrequency ablation of the great saphenous vein: analysis of early efficacy and complications. J Vasc Surg 2005; 42:488.</a></li><li><a class="nounderline abstract_t">Healy DA, Kimura S, Power D, et al. A Systematic Review and Meta-analysis of Thrombotic Events Following Endovenous Thermal Ablation of the Great Saphenous Vein. Eur J Vasc Endovasc Surg 2018; 56:410.</a></li><li><a class="nounderline abstract_t">Rhee SJ, Cantelmo NL, Conrad MF, Stoughton J. Factors influencing the incidence of endovenous heat-induced thrombosis (EHIT). Vasc Endovascular Surg 2013; 47:207.</a></li><li><a class="nounderline abstract_t">Lin JC, Peterson EL, Rivera ML, et al. Vein mapping prior to endovenous catheter ablation of the great saphenous vein predicts risk of endovenous heat-induced thrombosis. Vasc Endovascular Surg 2012; 46:378.</a></li><li><a class="nounderline abstract_t">Ahn S, Jung IM, Chung JK, Lee T. Changes in Saphenous Vein Stump and Low Incidence of Endovenous Heat-Induced Thrombosis After Radiofrequency Ablation of Great Saphenous Vein Incompetence. Dermatol Surg 2016; 42:515.</a></li><li><a class="nounderline abstract_t">Jones RT, Kabnick LS. Perioperative duplex ultrasound following endothermal ablation of the saphenous vein: is it worthless? J Invasive Cardiol 2014; 26:548.</a></li><li class="breakAll">Kabnick LS. Thrombus at the SFJ after endovenous ablation: What should I do now? Third International Vein Congress: In-office Techniques. Miami, FL 2005.</li><li><a class="nounderline abstract_t">Dunst KM, Huemer GM, Wayand W, Shamiyeh A. Diffuse phlegmonous phlebitis after endovenous laser treatment of the greater saphenous vein. J Vasc Surg 2006; 43:1056.</a></li><li><a class="nounderline abstract_t">Chang CJ, Chua JJ. Endovenous laser photocoagulation (EVLP) for varicose veins. Lasers Surg Med 2002; 31:257.</a></li><li><a class="nounderline abstract_t">de Medeiros CA, Luccas GC. Comparison of endovenous treatment with an 810 nm laser versus conventional stripping of the great saphenous vein in patients with primary varicose veins. Dermatol Surg 2005; 31:1685.</a></li><li><a class="nounderline abstract_t">Desmyttère J, Grard C, Wassmer B, Mordon S. Endovenous 980-nm laser treatment of saphenous veins in a series of 500 patients. J Vasc Surg 2007; 46:1242.</a></li><li><a class="nounderline abstract_t">Kane K, Fisher T, Bennett M, et al. The incidence and outcome of endothermal heat-induced thrombosis after endovenous laser ablation. Ann Vasc Surg 2014; 28:1744.</a></li><li><a class="nounderline abstract_t">Kalteis M, Berger I, Messie-Werndl S, et al. High ligation combined with stripping and endovenous laser ablation of the great saphenous vein: early results of a randomized controlled study. J Vasc Surg 2008; 47:822.</a></li><li><a class="nounderline abstract_t">Eroglu E, Yasim A. A Randomised Clinical Trial Comparing N-Butyl Cyanoacrylate, Radiofrequency Ablation and Endovenous Laser Ablation for the Treatment of Superficial Venous Incompetence: Two Year Follow up Results. Eur J Vasc Endovasc Surg 2018; 56:553.</a></li><li><a class="nounderline abstract_t">Shahid KR, Dellon AL, Amrami KK, Spinner RJ. Sciatic and peroneal nerve injuries after endovascular ablation of lower extremity varicosities: case reports and review of the literature. Ann Plast Surg 2015; 74:64.</a></li><li><a class="nounderline abstract_t">Merchant R Jr, Kistner RL, Kabnick LS. Is there an increased risk for DVT with the VNUS closure procedure? J Vasc Surg 2003; 38:628.</a></li><li><a class="nounderline abstract_t">Hingorani AP, Ascher E, Markevich N, et al. Deep venous thrombosis after radiofrequency ablation of greater saphenous vein: a word of caution. J Vasc Surg 2004; 40:500.</a></li><li><a class="nounderline abstract_t">Merchant RF, DePalma RG, Kabnick LS. Endovascular obliteration of saphenous reflux: a multicenter study. J Vasc Surg 2002; 35:1190.</a></li><li><a class="nounderline abstract_t">Manfrini S, Gasbarro V, Danielsson G, et al. Endovenous management of saphenous vein reflux. Endovenous Reflux Management Study Group. J Vasc Surg 2000; 32:330.</a></li><li><a class="nounderline abstract_t">Lurie F, Creton D, Eklof B, et al. Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): two-year follow-up. Eur J Vasc Endovasc Surg 2005; 29:67.</a></li><li><a class="nounderline abstract_t">Luebke T, Brunkwall J. Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. J Cardiovasc Surg (Torino) 2008; 49:213.</a></li><li><a class="nounderline abstract_t">van Rij AM, Hill G, Gray C, et al. A prospective study of the fate of venous leg perforators after varicose vein surgery. J Vasc Surg 2005; 42:1156.</a></li><li><a class="nounderline abstract_t">van den Bos R, Arends L, Kockaert M, et al. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 2009; 49:230.</a></li><li><a class="nounderline abstract_t">Sufian S, Arnez A, Labropoulos N, et al. Radiofrequency ablation of the great saphenous vein, comparing one versus two treatment cycles for the proximal vein segment. Phlebology 2015; 30:724.</a></li><li><a class="nounderline abstract_t">Proebstle TM, Vago B, Alm J, et al. Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience. J Vasc Surg 2008; 47:151.</a></li><li><a class="nounderline abstract_t">Bozoglan O, Mese B, Eroglu E, et al. Comparison of Endovenous Laser and Radiofrequency Ablation in Treating Varicose Veins in the Same Patient. Vasc Endovascular Surg 2016; 50:47.</a></li><li><a class="nounderline abstract_t">Perälä J, Rautio T, Biancari F, et al. Radiofrequency endovenous obliteration versus stripping of the long saphenous vein in the management of primary varicose veins: 3-year outcome of a randomized study. Ann Vasc Surg 2005; 19:669.</a></li><li><a class="nounderline abstract_t">Proebstle TM, Alm J, Göckeritz O, et al. Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities. J Vasc Surg 2011; 54:146.</a></li><li><a class="nounderline abstract_t">Helmy ElKaffas K, ElKashef O, ElBaz W. Great saphenous vein radiofrequency ablation versus standard stripping in the management of primary varicose veins-a randomized clinical trial. Angiology 2011; 62:49.</a></li><li><a class="nounderline abstract_t">Merchant RF, Pichot O, Closure Study Group. Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment for superficial venous insufficiency. J Vasc Surg 2005; 42:502.</a></li><li><a class="nounderline abstract_t">Kheirelseid EAH, Crowe G, Sehgal R, et al. Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower extremity varicose veins. J Vasc Surg Venous Lymphat Disord 2018; 6:256.</a></li><li><a class="nounderline abstract_t">O'Donnell TF Jr. The present status of surgery of the superficial venous system in the management of venous ulcer and the evidence for the role of perforator interruption. J Vasc Surg 2008; 48:1044.</a></li><li><a class="nounderline abstract_t">Tenbrook JA Jr, Iafrati MD, O'donnell TF Jr, et al. Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery. J Vasc Surg 2004; 39:583.</a></li><li><a class="nounderline abstract_t">Marrocco CJ, Atkins MD, Bohannon WT, et al. Endovenous ablation for the treatment of chronic venous insufficiency and venous ulcerations. World J Surg 2010; 34:2299.</a></li><li><a class="nounderline abstract_t">van den Bos RR, Wentel T, Neumann MH, Nijsten T. Treatment of incompetent perforating veins using the radiofrequency ablation stylet: a pilot study. Phlebology 2009; 24:208.</a></li><li><a class="nounderline abstract_t">Aurshina A, Hingorani A, Blumberg S, et al. Shortened protocol for radiofrequency ablation of perforator veins. J Vasc Surg Venous Lymphat Disord 2017; 5:824.</a></li></ol></div><div id="topicVersionRevision">Topic 8203 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19050803" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A review of literature along with a cadaveric study of the prevalence of the Giacomini vein (the thigh extension of the small saphenous vein) in the Indian population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17306952" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Endovenous laser treatment of the small [corrected] saphenous vein: efficacy and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15622372" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevalence, anatomic patterns, valvular competence, and clinical significance of the Giacomini vein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20022210" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The anatomy of the small saphenous vein: fascial and neural relations, saphenofemoral junction, and valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12170230" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Nomenclature of the veins of the lower limbs: an international interdisciplinary consensus statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18291167" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Surgical anatomy of the saphenous nerve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22503186" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The surgical anatomy of the small saphenous vein and adjacent nerves in relation to endovenous thermal ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26826266" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The sural nerve: Sonographic anatomy, variability and relation to the small saphenous vein in the setting of endovenous thermal ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21536172" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22421374" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Thermal ablation in the management of superficial thrombophlebitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17349355" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Adjunctive proximal vein ligation with endovenous obliteration of great saphenous vein reflux: does it have clinical value?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20646894" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Classification of proximal endovenous closure levels and treatment algorithm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26992337" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Incidence, progression, and risk factors for endovenous heat-induced thrombosis after radiofrequency ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30550518" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Incidence, Risk Factors, Progression, and Treatment of Endovenous Heat-Induced Thrombosis Class 2 or Greater After Endovenous Radiofrequency Ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16376206" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Can phlebectomy be deferred in the treatment of varicose veins?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16950441" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Endovenous ablation of the great saphenous vein may avert phlebectomy for branch varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26946896" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Factors that influence perforator vein closure rates using radiofrequency ablation, laser ablation, or foam sclerotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22516240" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Success of endovenous saphenous and perforator ablation in patients with symptomatic venous insufficiency receiving long-term warfarin therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20864301" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Effect of anticoagulation on endothermal ablation of the great saphenous vein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21029949" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular Interventional Radiological Society of Europe and Canadian Interventional Radiology Association [corrected].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11194816" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Role of duplex imaging in endovenous obliteration for primary venous insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26556697" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Radiofrequency ablation of varicose veins: Best practice techniques and evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23384556" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Endovenous radiofrequency ablation (venefit procedure): impact of different energy rates on great saphenous vein shrinkage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19299275" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Five-year results of incompetent perforator vein closure using TRans-Luminal Occlusion of Perforator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17437986" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Radiofrequency ablation of incompetent perforator veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20348454" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : One-year outcomes of radiofrequency ablation of incompetent perforator veins using the radiofrequency stylet device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17936486" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Endovenous radiofrequency ablation of superficial and perforator veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30392525" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A Randomised Clinical Trial of Buffered Tumescent Local Anaesthesia During Endothermal Ablation for Superficial Venous Incompetence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26895001" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Estimated Maximal Safe Dosages of Tumescent Lidocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Technical tip: cold saline infiltration instead of local anaesthetic in endovenous laser treatment</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35505452" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Reducing tumescent anesthetic injection pain by topical anesthesia pretreatment among patients undergoing endovenous radiofrequency ablation of varicose veins: A double-blind randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26992584" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Increasing ablation distance peripheral to the saphenofemoral junction may result in a diminished rate of endothermal heat-induced thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19065553" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Histological changes occurring after endoluminal ablation with two diode lasers (940 and 1319 nm) from acute changes to 4 months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20123189" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Multi-society consensus quality improvement guidelines for the treatment of lower-extremity superficial venous insufficiency with endovenous thermal ablation from the Society of Interventional Radiology, Cardiovascular Interventional Radiological Society of Europe, American College of Phlebology and Canadian Interventional Radiology Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29037350" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Prospective study of safety and effectiveness in the use of radiofrequency ablation for incompetent great saphenous vein≥12 mm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26993545" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Reflux in the below-knee great saphenous vein can be safely treated with endovenous ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27554689" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Compression versus No Compression after Endovenous Ablation of the Great Saphenous Vein: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25616874" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A randomised controlled trial comparing compression therapy after radiofrequency ablation for primary great saphenous vein incompetence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29680439" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The role of compression after endovenous ablation of varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35713027" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Compression versus no compression after endovenous radiofrequency ablation: A meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35232310" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Recovery and patient satisfaction following radiofrequency ablation and concomitant foam sclerotherapy of varicose veins with and without compression: A randomized controlled non-inferiority trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30959134" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Optimal duration of compression stocking therapy following endovenous thermal ablation for great saphenous vein insufficiency: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19395275" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12891099" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20537570" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Laser and radiofrequency ablation study (LARA study): a randomised study comparing radiofrequency ablation and endovenous laser ablation (810 nm).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20473992" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation versus laser for varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20638231" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A randomized, controlled trial of endovenous thermal ablation using the 810-nm wavelength laser and the ClosurePLUS radiofrequency ablation methods for superficial venous insufficiency of the great saphenous vein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21934487" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A prospective double-blind randomized controlled trial of radiofrequency versus laser treatment of the great saphenous vein in patients with varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19628516" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Saphenous laser ablation at 1470 nm targets the vein wall, not blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15696055" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23876422" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : ACCF/ACR/AIUM/ASE/IAC/SCAI/SCVS/SIR/SVM/SVS/SVU 2013 appropriate use criteria for peripheral vascular ultrasound and physiological testing part II: testing for venous disease and evaluation of hemodialysis access: a report of the american college of cardiology foundation appropriate use criteria task force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14718839" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Duplex ultrasound scan findings two years after great saphenous vein radiofrequency endovenous obliteration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12384650" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Ultrasound changes at the saphenofemoral junction and in the long saphenous vein during the first year after VNUS closure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16171593" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Endovenous laser therapy and radiofrequency ablation of the great saphenous vein: analysis of early efficacy and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29895399" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : A Systematic Review and Meta-analysis of Thrombotic Events Following Endovenous Thermal Ablation of the Great Saphenous Vein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23427285" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Factors influencing the incidence of endovenous heat-induced thrombosis (EHIT).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22649164" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Vein mapping prior to endovenous catheter ablation of the great saphenous vein predicts risk of endovenous heat-induced thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26981720" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Changes in Saphenous Vein Stump and Low Incidence of Endovenous Heat-Induced Thrombosis After Radiofrequency Ablation of Great Saphenous Vein Incompetence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25274866" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Perioperative duplex ultrasound following endothermal ablation of the saphenous vein: is it worthless?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25274866" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Perioperative duplex ultrasound following endothermal ablation of the saphenous vein: is it worthless?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16678705" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Diffuse phlegmonous phlebitis after endovenous laser treatment of the greater saphenous vein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12355571" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Endovenous laser photocoagulation (EVLP) for varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16336888" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Comparison of endovenous treatment with an 810 nm laser versus conventional stripping of the great saphenous vein in patients with primary varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18155001" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Endovenous 980-nm laser treatment of saphenous veins in a series of 500 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24911803" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The incidence and outcome of endothermal heat-induced thrombosis after endovenous laser ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18295441" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : High ligation combined with stripping and endovenous laser ablation of the great saphenous vein: early results of a randomized controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30042039" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : A Randomised Clinical Trial Comparing N-Butyl Cyanoacrylate, Radiofrequency Ablation and Endovenous Laser Ablation for the Treatment of Superficial Venous Incompetence: Two Year Follow up Results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25072312" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Sciatic and peroneal nerve injuries after endovascular ablation of lower extremity varicosities: case reports and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12968599" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Is there an increased risk for DVT with the VNUS closure procedure?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15337880" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Deep venous thrombosis after radiofrequency ablation of greater saphenous vein: a word of caution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12042730" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Endovascular obliteration of saphenous reflux: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10917994" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Endovenous management of saphenous vein reflux. Endovenous Reflux Management Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15570274" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): two-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18431342" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16376208" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : A prospective study of the fate of venous leg perforators after varicose vein surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18692348" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Endovenous therapies of lower extremity varicosities: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25326216" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Radiofrequency ablation of the great saphenous vein, comparing one versus two treatment cycles for the proximal vein segment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18178468" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26767802" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Comparison of Endovenous Laser and Radiofrequency Ablation in Treating Varicose Veins in the Same Patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16052388" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Radiofrequency endovenous obliteration versus stripping of the long saphenous vein in the management of primary varicose veins: 3-year outcome of a randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21439757" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20724299" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Great saphenous vein radiofrequency ablation versus standard stripping in the management of primary varicose veins-a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16171596" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment for superficial venous insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29292115" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower extremity varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18992425" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : The present status of surgery of the superficial venous system in the management of venous ulcer and the evidence for the role of perforator interruption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14981453" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20523994" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Endovenous ablation for the treatment of chronic venous insufficiency and venous ulcerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19767487" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Treatment of incompetent perforating veins using the radiofrequency ablation stylet: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29037353" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Shortened protocol for radiofrequency ablation of perforator veins.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
